Mead Johnson Launches Enfinitas® in China

Premium offering features ingredients based on breakthrough science

GLENVIEW, Ill.–(BUSINESS WIRE)–Mead Johnson Nutrition Company (NYSE:MJN) today announced the launch of
its new Enfinitas premium-priced product line in China, which will be
rolling out in that market over the coming weeks.

“As noted previously, Mead Johnson continually strives to further
broaden our science-based product portfolio,” commented Kasper Jakobsen,
President and CEO. “We are pleased to be introducing Enfinitas and its
meaningful benefits to consumers in China in support of our mission to
help nourish the world’s children for the best start in life. Over time,
we expect this product to strengthen our competitiveness in the
fastest-growing segment of our category in China.”

Enfinitas adopts the very latest science and advanced technology in
infant nutrition and is inspired by Mead Johnson’s comprehensive global
research and findings in human milk. That research, which has
accelerated over the past five years, has been carried out in
cooperation with multiple authoritative scientific research institutions
in studies covering populations in Asia, Europe, North America and South
America.

Specifically customized for the China market and produced in the
Netherlands, this new formulation has undergone extensive research.
Enfinitas contains Lactoferrin and Milk Fat Globule Membrane (MFGM) –
both of which are naturally present in breast milk and known to provide
structural and functional benefits to infants. Together with the
company’s gold standard level of DHA, these critical components help
support brain development, immune system function and digestive health.

Additional information will be provided on the Mead Johnson Nutrition
2016 first quarter earnings conference call.

About Mead Johnson Nutrition

Mead Johnson, a global leader in pediatric nutrition, develops,
manufactures, markets and distributes more than 70 products in over 50
markets worldwide. The company’s mission is to nourish the world’s
children for the best start in life. The Mead Johnson name has been
associated with science-based pediatric nutrition products for over 110
years. The company’s “Enfa” family of brands, including Enfamil® infant
formula, is the world’s leading brand franchise in pediatric nutrition.
For more information, go to www.meadjohnson.com.

Forward-Looking Statements

Certain statements in this news release are forward-looking as defined
in the Private Securities Litigation Reform Act of 1995. These
forward-looking statements may be identified by the fact they use words
such as “should,” “expect,” “anticipate,” “estimate,” “target,” “may,”
“project,” “guidance,” “intend,” “plan,” “believe” and other words and
terms of similar meaning and expression. Such statements are likely to
relate to, among other things, a discussion of goals, plans and
projections regarding financial position, results of operations, cash
flows, market position, product development, product approvals, sales
efforts, expenses, capital expenditures, performance or results of
current and anticipated products and the outcome of contingencies such
as legal proceedings and financial results. Forward-looking statements
can also be identified by the fact that they do not relate strictly to
historical or current facts. Such forward-looking statements are based
on current expectations that involve inherent risks, uncertainties and
assumptions that may cause actual results to differ materially from
expectations as of the date of this news release. These risks include,
but are not limited to: (1) the ability to sustain brand strength,
particularly the Enfa family of brands; (2) the effect on the company’s
reputation of real or perceived quality issues; (3) the effect of
regulatory restrictions related to the company’s products; (4) the
adverse effect of commodity costs; (5) increased competition from
branded, private label, store and economy-branded products; (6) the
effect of an economic downturn on consumers’ purchasing behavior and
customers’ ability to pay for product; (7) inventory reductions by
customers; (8) the adverse effect of changes in foreign currency
exchange rates; (9) the effect of changes in economic, political and
social conditions in the markets where we operate; (10) changing
consumer preferences; (11) the possibility of changes in the WIC*
program, or participation in WIC; (12) legislative, regulatory or
judicial action that may adversely affect the company’s ability to
advertise its products, maintain product margins, or negatively impact
the company’s reputation or result in fines or penalties that decrease
earnings; and (13) the ability to develop and market new, innovative
products. For additional information regarding these and other factors,
see the company’s filings with the United States Securities and Exchange
Commission (the SEC), including its most recent Annual Report on Form
10-K, which filings are available upon request from the SEC or at www.meadjohnson.com.
The company cautions readers not to place undue reliance on any
forward-looking statements, which speak only as of the date made. The
company undertakes no obligation to publicly update any forward-looking
statement, whether as a result of new information, future events or
otherwise.

* The Special Supplemental Nutrition Program for Women, Infants and
Children (WIC) is a federal assistance program of the Food and Nutrition
Services (FNS) of the United States Department of Agriculture (USDA).

Contacts

Mead Johnson Nutrition Company
Investors:
Kathy MacDonald,
(847) 832-2182
kathy.macdonald@mjn.com
or
Media:
Christopher
Perille, (847) 832-2178
chris.perille@mjn.com